Comparative proteomic analysis of neutrophils from patients with microscopic polyangiitis and granulomatosis with

Teisuke Uchida1, Kouhei Nagai, Toshiyuki Sato

  • 1Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa-ken, Japan.

Journal of Proteomics
|August 6, 2013
PubMed

Insights

This study analyzed neutrophil protein profiles to differentiate microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Distinct protein patterns in neutrophils can help diagnose these ANCA-associated vasculitis conditions.

Area of Science:

  • Immunology and Proteomics
  • Biomarker Discovery in Vasculitis

Background:

  • Microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are types of ANCA-associated vasculitis (AAV).
  • Neutrophils play a critical role in the pathology of AAV, but distinguishing between MPA and GPA can be challenging.

Purpose of the Study:

  • To investigate protein profiles of polymorphonuclear cells (PMNs) to discriminate between MPA, GPA, and healthy controls (HC).
  • To identify potential protein biomarkers for distinguishing MPA from GPA.

Main Methods:

  • Analysis of protein profiles in peripheral blood PMNs from 11 MPA patients, 9 GPA patients, and 10 HC using 2D-DIGE.
  • Identification of differentially expressed protein spots using mass spectrometry.
  • Statistical analysis including ANOVA, orthogonal partial-least-squares-discriminate analysis, and ROC analysis.

Main Results:

  • Significant differences in protein spot intensities were observed among MPA, GPA, and HC groups.
  • Protein profiles successfully discriminated AAV patients from HC, and MPA patients from GPA patients.
  • 13 protein spots, representing 10 distinct proteins, were identified as potential biomarkers differentiating MPA and GPA.

Conclusions:

  • PMN protein profiles are valuable for distinguishing between MPA, GPA, and healthy individuals.
  • The identified 10 proteins represent novel biomarkers for diagnosing MPA and GPA.
  • These protein differences may reflect underlying distinct pathophysiological mechanisms in MPA versus GPA.

Related Concept Videos